According to SEC filings for the period ending September 2025, Inhibikase Therapeutics, Inc. (NASDAQ:IKT) is held by 54 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 30 Sep, 2025 | 10,950,000 | 0 | 0.00% | $17,739,000.00 |
| Soleus Capital Management, L.P. | 30 Sep, 2025 | 6,325,000 | 0 | 0.00% | $10,246,500.00 |
| Fairmount Funds Management LLC | 30 Sep, 2025 | 6,125,000 | 0 | 0.00% | $9,922,500.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 5,421,568 | -10,725 | -0.20% | $8,782,940.00 |
| Commodore Capital LP | 30 Sep, 2025 | 5,397,488 | 0 | 0.00% | $8,743,931.00 |
| ADAR1 Capital Management, LLC | 30 Sep, 2025 | 5,247,603 | 125,498 | 2.45% | $8,501,117.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 3,273,339 | 48,969 | 1.52% | $5,302,809.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,075,186 | 347,018 | 12.72% | $4,981,802.00 |
| Blackstone Inc. | 30 Sep, 2025 | 2,638,276 | 0 | 0.00% | $4,274,007.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 2,190,000 | 0 | 0.00% | $3,547,800.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,112,574 | 45,874 | 4.30% | $1,802,466.00 |
| Stonepine Capital Management, LLC | 30 Sep, 2025 | 735,019 | 1,226 | 0.17% | $1,190,731.00 |
| STATE STREET CORP | 30 Sep, 2025 | 507,749 | 109,937 | 27.64% | $822,553.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 374,336 | -18,380 | -4.68% | $606,424.00 |
| BLAIR WILLIAM & CO/IL | 30 Sep, 2025 | 152,953 | -4,000 | -2.55% | $247,784.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 152,298 | 0 | 0.00% | $246,723.00 |
| Bank of New York Mellon Corp | 30 Sep, 2025 | 138,667 | 6,194 | 4.68% | $224,641.00 |
| UBS Group AG | 30 Sep, 2025 | 136,280 | 97,606 | 252.38% | $220,773.00 |
| FMR LLC | 30 Sep, 2025 | 105,770 | -38,469 | -26.67% | $171,347.00 |
| BARCLAYS PLC | 30 Sep, 2025 | 85,578 | -24,674 | -22.38% | $138,636.00 |